Kripthonite Therapeutics is a Danish biotech company, originating from nearly 14 years of research at Aarhus University. Kripthonite is developing a drug targeting hypoxic cancer cells that cannot be removed surgically. These hypoxic cancer cells are resistant to traditional treatment methods such as radiation and chemotherapy. The treatment works by killing the hypoxic cancer cells – without harming healthy cells.

Zyneyro is a Danish biotech company, founded by researchers from the Department of Neuroscience at the University of Copenhagen after more than 15 years of research. The company is developing a drug for chronic neuropathic pain. Zyneyro’s drug candidate aims to provide effective and long-lasting pain relief without the risk of addiction. Zyneyro’s drug candidate is particularly effective against neuropathic pain.

NeoTargets is a Swedish platform company, where the researchers behind the project have spent more than 15 years developing a platform technology that can filter out targets with a risk of severe side effects, while at the same time ranking targets based on efficacy in the specific cancer type, thereby selecting the best drug candidate.